Dr. Kathleen Ruddy - the stories of 3 vaccinated patients with aggressive cancer who used ivermectin

lababouche
Published on Jun 16, 2025
source https://x.com/i/status/1934283462946455796
Dr. Kathleen Ruddy, a breast cancer surgeon, shared a compelling account of three patients with advanced, aggressive cancers who experienced remarkable outcomes after using ivermectin. These cases, though anecdotal, spark critical questions about the potential of repurposed medications in oncology, a field often limited by pharmaceutical industry priorities.

The first patient, Paul Mann, a 53-year-old marathoner with no family history of cancer, was diagnosed with stage four prostate cancer two months after receiving two Pfizer vaccines. Given weeks to live, Mann chose ivermectin. Defying his terminal prognosis, he now dances for hours multiple nights a week. Though his tumor has not fully regressed, he is exploring additional repurposed drugs.

The second patient, a man in his late sixties, had unresectable esophageal carcinoma with two lesions. Rejecting chemo and radiation, he used ivermectin alone. Within six to eight weeks, his tumors disappeared entirely—a result Dr. Ruddy notes could not be attributed to any other intervention.

The third patient, a woman with an 18-centimeter pelvic tumor originating from her stomach lining, underwent complex resection with negative margins. Despite postoperative liver metastases, she started ivermectin, and her metastatic lesions cleared completely. Her recovery was notably smooth.

Dr. Ruddy, drawing on her expertise in breast cancer surgery, stresses that these three cases, while not a large-scale study, are striking in their consistency. She acknowledges that pharmaceutical companies and academic institutions are unlikely to fund research into low-cost, off-patent drugs like ivermectin.

Yet, she argues, “Three patients in a row is a lot considering their response.” This has driven her to advocate for a strategic, ethical, and scientifically sound investigation into whether ivermectin and other repurposed medications could enhance cancer survival.

These observations challenge the medical community to explore accessible treatment options. While not a replacement for rigorous clinical trials, these outcomes demand further scrutiny to assess if repurposed drugs could offer hope to patients with few alternatives.

Dr. Ruddy’s insights, rooted in her surgical expertise and patient experiences, urge a reevaluation of innovation in cancer care.
Expose the Globalists tyranny
https://expose1984.com
Proof that the pandemic was planned
https://stopworldcontrol.com/
Lien vers le site web de balance la babouche archivé
https://expose1984.com/balancemababouche
Le site des gardiens du vivant archivé
https://expose1984.com/desgardiens
Dr. Kathleen Ruddy - the stories of 3 vaccinated patients with aggressive cancer who used ivermectin https://old.bitchute.com/video/DLk77nrj18XV/

Add to

Please Sign In or Create Account to use this feature!

Flag Video

Please Sign In or Create Account to use this feature!

Rate video

Please Sign In or Create Account to use this feature!

Rate video

Please Sign In or Create Account to use this feature!

DISCLAIMER

The content presented in this stream and/or video may be satirical in nature for entertainment purposes. It may contain realistic scenarios that may include themes of racism, anti-semitism, anti-LGBT sentiment and even elements such as death threats, all purely in the context of parody. In addition, this content may depict or refer to acts of violence in a satirical manner. Shock factor is a common and deliberate element used in these displays to emphasise the satirical message. By continuing to view this content, you acknowledge that you understand the satirical nature of this content, including the depiction of violence and the use of shock factor, and agree that you will not use or interpret this content outside of its intended context. Please remember that humour and satire are complex; they are not intended to belittle or demean, but to engage and challenge social norms through exaggeration. If you have any concerns about content, please feel free to engage in constructive dialogue or report issues to GTV staff.